Kylo Peptides Launches Bulk Peptides Program for High-Volume Laboratories

Sheridan, Wyoming, Oct. 06, 2026 /CourierPR/ -- Kylo Peptides, a chemical supplier based in Sheridan, Wyoming, has launched a new research program aimed at supporting high-volume laboratories with bulk peptides. The program, which is designed to meet the needs of universities, contract research organizations (CROs), and biotech teams, offers a streamlined process for ordering and managing bulk peptides.

The new initiative addresses the specific requirements of laboratories that need to conduct repeated experiments or long-term studies using the same compound. According to Dr. Rupert Mills, a process chemist at Kylo Peptides, the program ensures that each lot of peptides is reserved for the duration of the study, providing researchers with a consistent and reliable supply.

Under the bulk research program, Kylo Peptides offers lot reservation for the duration of the study, along with a certificate of analysis (COA), chromatograms, and net-content data for each lot. The company also provides an account manager to supply lead times and a line sheet, helping researchers plan their material needs effectively.

For chemists and procurement staff, the core questions remain the same at any scale: what the material is, which batch it came from, and what analytical data supports it. Kylo Peptides ensures that researchers can confirm the identity of the peptide by comparing the product designation, sequence, and any chemical modifications against their project specification. The company also provides molecular formula and molecular mass for an additional check.

Kylo Peptides emphasizes the importance of batch identification for peptide research. Each lot is printed with a unique identifier, and the company maintains a public COA library that lists certificates by lot ID. Researchers are advised to log the batch, quantity, date received, and associated records upon arrival. This helps in tracking material usage and forecasting future requirements.

The company's guidance for storing lyophilized vials is to keep them at -20°C, sealed and protected from light and moisture. After reconstitution with a sterile diluent, the guidance is to store the vials at 2 to 8°C, with prompt use and no repeated freeze-thaw cycles. Labels and lot numbers should remain with each vial throughout storage, and minimal handling is recommended to protect the materials from unsuitable conditions.

Kylo Peptides' bulk research program is designed to support recurring research requirements, with protocols that repeat on a fixed schedule. The company provides custom quotes for repeat orders, ensuring that researchers can estimate each cycle's consumption in advance. This helps in aligning peptide procurement with the research calendar and maintaining a consistent supply.

The program also addresses the need for analytical documentation. Each COA records how peptide research materials were characterized, listing product identity, batch number, reported purity, analytical results, and testing information. Kylo's certificates are issued by four independent laboratories: Janoshik Analytical, Freedom Diagnostics, Vanguard Laboratory, and Optiq Health Labs.

Kylo Peptides, which was started in 2021 by process chemists and QC analysts, supplies research peptides for preclinical and in vitro work. The company states that it publishes a lot-matched certificate for each released batch. The bulk research program is intended for laboratory, analytical, and in vitro work only, and is not approved for therapeutic or human use.

In summary, Kylo Peptides' bulk research program offers a comprehensive solution for high-volume laboratories, ensuring that researchers have the necessary tools to conduct their studies with confidence and precision.